Stay updated on AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial

Sign up to get notified when there's something new on the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:57:01.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:57:02.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page has removed detailed information about a clinical trial for AGTC-401 related to achromatopsia, including study endpoints, inclusion and exclusion criteria, and specific age groups for participants. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    22%
    Check dated 2025-04-16T02:00:17.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T21:50:15.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T18:29:59.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    The page has removed references to Applied Genetic Technologies Corp and its association with Beacon Therapeutics, while adding a note about heavy traffic affecting NLM-NCBI services and providing contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:23:02.000Z thumbnail image

Stay in the know with updates to AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page.